Ensayo clínico

Desarrollo de FAPI PET como Biomarcador No Invasivo de Fibrosis Pulmonar

NCT: NCT06940427 · RECRUITING

ID NCTNCT06940427

EstadoRECRUITING

Fecha de inicio2025-11-19

SponsorUniversity of Wisconsin, Madison (OTHER)

First posted2025-04-23

Last updated2026-10-01

Resumen breve

The goal of this clinical trial is to gain more information about how fibroblast activation protein inhibitor (FAPI) binds to a certain type of cells in fibrotic lung tissue and how this information can be used to better diagnose and track fibrotic lung disease activity. Participants will undergo up to 4 PET/MRI scans using the FAPI radiotracer.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.